ATS Highlights

Kirsten Almberg – Black lung, lung cancer, COPD in US coal miners

At the American Thoracic Society meeting, Dr Kirsten Almberg discussed the rise of black lung, lung cancer, and chronic obstructive pulmonary disease (COPD) in US coal miners. Here, she reiterates the results of two studies assessing mortality in US-based coal miners and the further work that needs to be done to better understand the health […]

Airway and Lung Infection, COPD

Hiroki Tateno – Novel CureApp for smoking cessation

At the American Thoracic Society meeting, Dr Hiroki Tateno shared the results of a randomized, sham-controlled, open-label study to evaluate the long-term efficacy of CureApp, a novel smoking cessation app (CureApp Inc.), when used in addition to pharmacotherapy. Questions 1. What smoking cessation aids are currently available and how successful have they been in achieving […]

Interventional Pulmonology

Frank Sciurba, ATS 2019 – Reduction in Hyperinflation with Zephyr Endobronchial Valves

At the 2019 ATS conference in Dallas, TX, USA, Frank Sciurba (University of Pittsburgh Medical Centre, Pittsburgh, PA, USA) discusses the challenges faced by patients with heterogeneous emphysema with negative collateral ventilation (CV) status and the potential of the Zephyr Valve to improve lung function, exercise tolerance and quality of life. Questions 1. What challenges […]

Pulmonary Hypertension

Sandeep Sahay, ATS 2019 – New World Symposium Proceedings on Pulmonary Hypertension

Sandeep Sahay (Houston Methodist Lung Center, Houston Methodist Hospital, Houston, TX, USA) speaks from the 2019 ATS conference in Dallas, TX, USA about portopulmonary hypertension, how it differs from other types of hypertension and changes to the diagnostic criteria. He also addresses the changes this will have on patients and addressing unmet needs in hypertension. […]

Sleep Related Breathing Disorders

Babak Mokhlesi, ATS 2019 – Impact Obstructive Sleep Apnea and Duration on Glucose Tolerance (Part 1)

Speaking at the 2019 ATS conference in Dallas, TX, USA, Babak Mokhlesi (University of Chicago, Chicago, IL, USA) discusses the link between obstructive sleep apnoea, insufficient sleep duration and type 2 diabetes; key findings of his study, and the implications for the prevention and treatment of type 2 diabetes. Questions 1. What is the link […]

Sleep Related Breathing Disorders

Babak Mokhlesi, ATS 2019 – Impact Obstructive Sleep Apnea and Duration on Glucose Tolerance (Part 2)

Respiratory Intensive Care

Jacqueline Kruser, ATS 2019 – Quality of End-of-Life Care in the Intensive Care Unit

At the 2019 ATS conference in Dallas, TX, USA, Jacqueline Kruser (Northwestern University, Chicago, IL, USA) discusses the knowledge gap in end-of-life (EOL) care and the implications of her study findings in terms of meeting unmet needs in EOL care in patients in the ICU. Questions 1. What is currently known about end-of-life (EOL) care […]

Respiratory Intensive Care

Margaret Pisani, ATS 2019 – Delirium in the ICU

Margaret Pisani (Yale University School of Medicine, New Haven, CT, USA) speaks from the 2019 ATS conference in Dallas, TX, USA about the impact of delirium in the intensive care unit (ICU) and new evidence on the potential benefits of pharmacological interventions to manage delirium. She also discusses the unmet needs for ICU patients with […]

Asthma, COPD

Nirupama Putcha and Elizabeth Oelsner, ATS 2019 – Asthma COPD Overlap, NHLBI Pooled Cohorts Study

Nirupama Putcha (Johns Hopkins University, Baltimore, MD, USA) and Elizabeth Oelsner (Columbia University Medical Center, New York, NY, USA) speak from the 2019 ATS conference in Dallas, TX, USA about their study into patients with asthma–chronic obstructive pulmonary disease (COPD) overlap (ACO) and its prognostic impact compared with asthma and COPD; the implications of their […]

FILTER YOUR SEARCH

Speciality: